PMID- 16253900 OWN - NLM STAT- MEDLINE DCOM- 20060127 LR - 20220409 IS - 1521-6918 (Print) IS - 1521-6918 (Linking) VI - 19 IP - 5 DP - 2005 Oct TI - Insulinoma. PG - 783-98 AB - Although rare, insulinomas are the most common functioning islet cell tumour of the pancreas. Recognition of the key neuroglycopenic symptoms should trigger the initial investigation. Biochemical proof of endogenous hyperinsulinemic hypoglycemia establishes the diagnosis. Several options are available for imaging and localizing these tumours including ultrasonography, computed tomography, and intra-arterial calcium stimulation with venous sampling. The tumours are usually small, single, benign, well-circumscribed, and evenly distributed throughout the pancreas. This tumour may be a part of the multiple endocrine neoplasia type 1 (MEN-1) syndrome, in which case the tumours are almost always multiple. Surgical treatment is the only curative method, traditionally accomplished with enucleation or partial pancreatic resection. Patients are almost invariably cured lifelong with complete excision of a benign insulinoma. The most recent developments in this area are the recognition of noninsulinoma pancreatogenous hypoglycemia syndrome as a cause of organic hypoglycemia, and the development of laparoscopic techniques to excise these tumours. FAU - Grant, Clive S AU - Grant CS AD - Department of Surgery, Mayo Clinic College of Medicine, Mayo Clinic, 200 First Street, SW Rochester, MN 55905, USA. cgrant@mayo.edu LA - eng PT - Journal Article PT - Review PL - Netherlands TA - Best Pract Res Clin Gastroenterol JT - Best practice & research. Clinical gastroenterology JID - 101120605 SB - IM MH - Adolescent MH - Adult MH - Age Distribution MH - Aged MH - Aged, 80 and over MH - Biopsy, Needle MH - Endosonography/methods MH - Female MH - Humans MH - Immunohistochemistry MH - Incidence MH - Insulinoma/*diagnosis/epidemiology/*surgery MH - Male MH - Middle Aged MH - Neoplasm Staging MH - Pancreatectomy/*methods MH - Pancreatic Neoplasms/*diagnosis/epidemiology/*surgery MH - Phlebography/methods MH - Prognosis MH - Rare Diseases MH - Risk Assessment MH - Sex Distribution MH - Survival Rate MH - Tomography, X-Ray Computed/methods MH - Treatment Outcome RF - 52 EDAT- 2005/10/29 09:00 MHDA- 2006/01/28 09:00 CRDT- 2005/10/29 09:00 PHST- 2005/10/29 09:00 [pubmed] PHST- 2006/01/28 09:00 [medline] PHST- 2005/10/29 09:00 [entrez] AID - S1521-6918(05)00094-6 [pii] AID - 10.1016/j.bpg.2005.05.008 [doi] PST - ppublish SO - Best Pract Res Clin Gastroenterol. 2005 Oct;19(5):783-98. doi: 10.1016/j.bpg.2005.05.008.